133 related articles for article (PubMed ID: 20443723)
1. Multimodality magnetic resonance imaging of prostate cancer.
Engelbrecht MR; Puech P; Colin P; Akin O; Lemaître L; Villers A
J Endourol; 2010 May; 24(5):677-84. PubMed ID: 20443723
[TBL] [Abstract][Full Text] [Related]
2. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance.
Villers A; Lemaitre L; Haffner J; Puech P
Curr Opin Urol; 2009 May; 19(3):274-82. PubMed ID: 19325494
[TBL] [Abstract][Full Text] [Related]
3. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
[TBL] [Abstract][Full Text] [Related]
4. Role of high-field MR in studies of localized prostate cancer.
Lagemaat MW; Scheenen TW
NMR Biomed; 2014 Jan; 27(1):67-79. PubMed ID: 23703839
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
7. [Endorectal magnetic resonance imaging for staging of prostatic cancer].
Hayashi N; Kawamura J; Sugimura Y
Hinyokika Kiyo; 1996 Oct; 42(10):767-73. PubMed ID: 8951473
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.
Styles C; Ferris N; Mitchell C; Murphy D; Frydenberg M; Mills J; Pedersen J; Bergen N; Duchesne G
J Med Imaging Radiat Oncol; 2014 Aug; 58(4):439-48. PubMed ID: 24935089
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
Durmus T; Baur A; Hamm B
Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging detects significant prostate cancer with high probability.
Bains LJ; Studer UE; Froehlich JM; Giannarini G; Triantafyllou M; Fleischmann A; Thoeny HC
J Urol; 2014 Sep; 192(3):737-42. PubMed ID: 24641913
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
13. Update of prostate magnetic resonance imaging at 3 T.
Kim CK; Park BK
J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296
[TBL] [Abstract][Full Text] [Related]
14. Inapparent tumor on endorectal multimodality magnetic resonance imaging of prostate: should we perform a biopsy?
Labanaris AP; Engelhard K; Zugor V; Witt JH; Kühn R
Urology; 2011 Jul; 78(1):116-20. PubMed ID: 21333339
[TBL] [Abstract][Full Text] [Related]
15. Role of 3T multiparametric magnetic resonance imaging without endorectal coil in the detection of local recurrent prostate cancer after radical prostatectomy: the radiation oncology point of view.
Couñago F; del Cerro E; Recio M; Díaz AA; Marcos FJ; Cerezo L; Maldonado A; Rodríguez-Luna JM; Thuissard I; Martin JL
Scand J Urol; 2015; 49(5):360-5. PubMed ID: 25652562
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance imaging and prostate cancer].
Cornud F; Villers A; Mongiat-Artus P; Rebillard X; Soulie M;
Prog Urol; 2008 Nov; 18(10):621-33. PubMed ID: 18971104
[TBL] [Abstract][Full Text] [Related]
17. The expanding role of MRI in prostate cancer.
Murphy G; Haider M; Ghai S; Sreeharsha B
AJR Am J Roentgenol; 2013 Dec; 201(6):1229-38. PubMed ID: 24261361
[TBL] [Abstract][Full Text] [Related]
18. [Endorectal magnetic resonance imaging of the prostate and bladder].
Sugimura Y; Hayashi N; Yamashita A; Kinbara H; Arima K; Tochigi H; Kawamura J
Hinyokika Kiyo; 1994 Jan; 40(1):31-6. PubMed ID: 7509118
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
Liauw SL; Pitroda SP; Eggener SE; Stadler WM; Pelizzari CA; Vannier MW; Oto A
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):378-84. PubMed ID: 22717242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
